Form D · Biotechnology
Orchard Therapeutics plc
London, X0 · CIK 0001748907
Offering snapshot reported Mar 23, 2023 · SEC filing
- Reported sold
- $34M Indefinite offering
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2023 | Initial | $34,000,140 | No comparison | 7 | SEC filing |
| Feb 24, 2021 | Initial | $149,999,996 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $3.24M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-476769
Total offering amount includes aggregate exercise price of ordinary shares and non-voting ordinary shares underlying warrants, which cannot be determined at this time.
Amount includes $1,020,004 paid in connection with the initial closing, $1,020,000 payable if and when the second closing occurs, and $1,200,000 payable if and when warrants are exercised and certain conditions are met.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| GUGGENHEIM SECURITIES, LLC | 40638 |
Source: Form D, filed Mar 23, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven M. Altschuler | Director |
| Joanne T. Beck | Director |
| John T. Curnutte | Director |
| Marc Dunoyer | Director |
| Jon Ellis | Director |
| Bobby Gaspar | Director, Executive |
| James A. Geraghty | Director |
| Charles A. Rowland Jr. | Director |
| Charles A. Rowland, Jr. | Director |
| Alicia Secor | Director |
| Frank E. Thomas | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
245 Hammersmith Road
London, X0, W6 8PW
London, X0, W6 8PW